MedWatch

Rhovac hires investment bank to generate interest in lead candidate

Biotech company Rhovac is on the lookout for a deal or a partnership regarding its lead candidate. International investment managing firm Stifel Nicolaus Europe has been appointed to help with the task.

Photo: Jens Dresling

Danish biotech company Rhovac, spearheaded by Anders Månsson, former executive of  Leo Pharma and Ferring Pharmaceuticals, has made it its goal to examine the opportunities of either striking a deal or entering a partnership pertaining to its lead candidate RV001, the company reports in a press relase on Monday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs